Interpace Biosciences, Inc. SEC filings IDXG
Interpace Biosciences, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Nov 6, 2003. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-A12B | Filing | Nov 5, 2026 | — |
| DRS | Filing | Jul 22, 2026 | — |
| D | Filing | Oct 16, 2024 | — |
| RW | Filing | Jun 16, 2022 | — |
| POS EX | Filing | Jan 13, 2022 | — |
| EFFECT | Filing | Jan 12, 2022 | — |
| CORRESP | Letter to the SEC | Jan 10, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 10, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 27, 2021 | — |
| CORRESP | Letter to the SEC | Aug 20, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 11, 2021 | — |
| 25-NSE | Delisting notice | Apr 26, 2021 | — |
| NT 10-K | Filing | Apr 1, 2021 | Dec 31, 2020 |
| NT 10-Q | Filing | Nov 17, 2020 | Sep 30, 2020 |
| NT 10-Q | Filing | Aug 14, 2020 | Jun 30, 2020 |
| D | Filing | Jan 27, 2020 | — |
| D | Filing | Jul 29, 2019 | — |
| EFFECT | Filing | Oct 19, 2018 | — |
| CORRESP | Letter to the SEC | Oct 17, 2018 | — |
| UPLOAD | Letter from the SEC | Oct 16, 2018 | — |
| D | Filing | Oct 16, 2017 | — |
| DEFR14A | Filing | Aug 16, 2017 | — |
| EFFECT | Filing | Jun 15, 2017 | — |
| CORRESP | Letter to the SEC | Jun 14, 2017 | — |
| CORRESP | Letter to the SEC | Jun 14, 2017 | — |
| CORRESP | Letter to the SEC | Jun 13, 2017 | — |
| CORRESP | Letter to the SEC | Jun 13, 2017 | — |
| D | Filing | Jan 27, 2017 | — |
| NT 10-Q | Form nt 10-q | Nov 14, 2016 | Sep 30, 2016 |
| EFFECT | Filing | Oct 9, 2015 | — |
| CORRESP | Letter to the SEC | Oct 8, 2015 | — |
| CORRESP | Letter to the SEC | Oct 7, 2015 | — |
| UPLOAD | Letter from the SEC | Oct 7, 2015 | — |
| CT ORDER | Filing | Oct 2, 2014 | — |
| UPLOAD | Letter from the SEC | Nov 29, 2013 | — |
| CORRESP | Letter to the SEC | Oct 17, 2013 | — |
| UPLOAD | Letter from the SEC | Oct 7, 2013 | — |
| CT ORDER | Filing | Sep 10, 2013 | — |
| CORRESP | Letter to the SEC | Jul 31, 2013 | — |
| CORRESP | Letter to the SEC | Jul 12, 2013 | — |
| UPLOAD | Letter from the SEC | Jul 3, 2013 | — |
| CT ORDER | Filing | Apr 23, 2012 | — |
| EFFECT | Filing | Jul 15, 2011 | — |
| CORRESP | Letter to the SEC | Jul 14, 2011 | — |
| CORRESP | Letter to the SEC | Jul 14, 2011 | — |
| CORRESP | Letter to the SEC | Jun 17, 2011 | — |
| UPLOAD | Letter from the SEC | Jun 10, 2011 | — |
| CT ORDER | Filing | Feb 24, 2011 | — |
| UPLOAD | Letter from the SEC | Feb 8, 2011 | — |
| CORRESP | Letter to the SEC | Jan 7, 2011 | — |
| CORRESP | Letter to the SEC | Dec 28, 2010 | — |
| CORRESP | Letter to the SEC | Dec 23, 2010 | — |
| CORRESP | Letter to the SEC | Nov 23, 2010 | — |
| UPLOAD | Letter from the SEC | Nov 15, 2010 | — |
| CORRESP | Letter to the SEC | Oct 25, 2010 | — |
| CORRESP | Letter to the SEC | Oct 5, 2010 | — |
| UPLOAD | Letter from the SEC | Sep 27, 2010 | — |
| CORRESP | Letter to the SEC | Sep 2, 2010 | — |
| CORRESP | Letter to the SEC | Aug 23, 2010 | — |
| CORRESP | Letter to the SEC | Aug 4, 2010 | — |
| UPLOAD | Letter from the SEC | Aug 4, 2010 | — |
| UPLOAD | Letter from the SEC | Jul 29, 2010 | — |
| CORRESP | Letter to the SEC | Jul 14, 2010 | — |
| UPLOAD | Letter from the SEC | Oct 20, 2008 | — |
| CORRESP | Letter to the SEC | Sep 29, 2008 | — |
| UPLOAD | Letter from the SEC | Sep 15, 2008 | — |
| UPLOAD | Letter from the SEC | Sep 15, 2008 | — |
| CORRESP | Letter to the SEC | Aug 15, 2008 | — |
| CORRESP | Letter to the SEC | Jul 9, 2008 | — |
| UPLOAD | Letter from the SEC | Nov 1, 2006 | — |
| UPLOAD | Letter from the SEC | Nov 1, 2006 | — |
| UPLOAD | Letter from the SEC | Nov 1, 2006 | — |
| CORRESP | Letter to the SEC | Oct 13, 2006 | — |
| CORRESP | Letter to the SEC | Sep 15, 2006 | — |
| NT 10-K | Pdi form 12b-25 (10-k extension) | Mar 17, 2006 | Dec 31, 2005 |
| DEFR14A | Filing | May 12, 2005 | — |
Showing 76 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- IDXG (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Parsippany, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1054102
- Former names
- Interpace Diagnostics Group, Inc. (until Nov 1, 2019); PDI INC (until Dec 22, 2015); PROFESSIONAL DETAILING INC (until Nov 13, 2002)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.